bromouracil has been researched along with ASC Atypical Squamous Cells in 1 studies
Bromouracil: 5-Bromo-2,4(1H,3H)-pyrimidinedione. Brominated derivative of uracil that acts as an antimetabolite, substituting for thymine in DNA. It is used mainly as an experimental mutagen, but its deoxyriboside (BROMODEOXYURIDINE) is used to treat neoplasms.
5-bromouracil : A pyrimidine having keto groups at the 2- and 4-positions and a bromo group at the 5-position. Used mainly as an experimental mutagen.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| THRELKELD, SF | 1 |
1 other study available for bromouracil and ASC Atypical Squamous Cells
| Article | Year |
|---|---|
Effect of 5-bromouracil on ascus patterns in some Neurospora crosses.
Topics: Atypical Squamous Cells of the Cervix; Bromouracil; Female; Humans; Neurospora; Uracil | 1962 |